Infant Bacterial Therapeutics AB (publ) IBT.B
Updated: 9 Aug 2026
No signal published yet
We already track Infant Bacterial Therapeutics and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.
Email when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
Temporary check — not Firelda's published signal.
General analysis — not personal advice.
Want to follow Infant Bacterial Therapeutics AB (publ)? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.
Follow Infant Bacterial Therapeutics free Follow freeEmail when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
Recent News
On July 7, 2026, the company announced that Chief Financial Officer Maria Ekdahl will leave her position on October 7, 2026. On May 6, 2026, IBT published its Q1 2026 interim report and highlighted ongoing constructive interactions with the US FDA ahead of a planned BLA submission for IBP-9414 in 2026.
What Firelda Watch includes for Infant Bacterial Therapeutics AB (publ)
Add the company to your watchlist and get all of this automatically.
- Free: 3 companies on your watchlist
- Change history and monitoring for every company you follow
- Sunday weekly brief — a short weekly roundup
- Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
Want to follow Infant Bacterial Therapeutics AB (publ)? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.
Follow Infant Bacterial Therapeutics free Follow freeEmail when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more